If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Statement re Share Consolidation

30 Sep 2014 15:11

RNS Number : 0490T
Maven Income & Growth VCT 4 PLC
30 September 2014
 

MAVEN INCOME AND GROWTH VCT 4 PLC

 

Completion of Share Consolidation

 

30 September 2014

 

This announcement is made by Maven Income and Growth VCT 4 plc ("the Company") in connection with the consolidation ("Share Consolidation") of the C ordinary shares of 10p each in the capital of the Company ("C Shares") into the ordinary shares of 10p each in the capital of the Company ("Ordinary Shares").

 

The Board of the Company is pleased to advise that the Share Consolidation has today been implemented, in accordance with the articles of association of the Company, as follows:

 

· 3,863,876 C Shares have been redesignated as 3,077,827 Ordinary Shares (based on a conversion ratio of 0.796847454551093 per holding of C Shares and rounded down to the nearest whole share); and

 

· the balance of the C Shares held by a C Shareholder which were not redesignated as Ordinary Shares were redesignated as deferred shares of 10p each, all of which have been bought back by the Company for an aggregate price of 1p and cancelled.

 

As a result of the above, the issued share capital of the Company now forms one class of share, Ordinary Shares, 32,499,188 of which are in issue. No Ordinary Shares are held in treasury by the Company.

 

Application has been made to the UKLA and the London Stock Exchange for amendments to the listing of the Ordinary Shares and C Shares to reflect the Share Consolidation.

 

Shareholders who hold their existing C Shares in certificated form will receive replacement certificates in respect of the Ordinary Shares arising from the Share Consolidation and existing share certificates in respect of C Shares will no longer be valid. Shareholders who hold their C Shares in CREST will have their CREST accounts updated.

 

For further enquiries please contact:

 

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRZBLFXZKFFBBB
Date   Source Headline
9th Nov 20233:49 pmRNSResult of General Meeting
13th Oct 20234:56 pmRNSPublication of a Prospectus
13th Oct 202310:17 amRNSDirector/PDMR Shareholding
13th Oct 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
6th Oct 20232:39 pmRNSStatement re Dividend Investment Scheme
8th Sep 20235:01 pmRNSTransaction in Own Shares-Corrective announcement
7th Sep 20233:35 pmRNSTransaction in Own Shares
30th Aug 20232:02 pmRNSHalf-year Report
17th Aug 20233:26 pmRNSStatement re NAV and Interim Dividend
12th Jul 20234:09 pmRNSHolding(s) in Company
10th Jul 20235:06 pmRNSHolding(s) in Company
2nd Jun 202310:05 amRNSDirector/PDMR Shareholding
2nd Jun 20239:43 amRNSIssue of Equity
24th May 20235:10 pmRNSTransaction in Own Shares
23rd May 202310:18 amRNSDirector/PDMR Shareholding
23rd May 202310:17 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20233:38 pmRNSNet Asset Value(s) - Dividend Investment Scheme
11th May 20233:01 pmRNSResult of AGM
11th May 20232:20 pmRNSNet Asset Value(s)
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
13th Apr 20237:00 amRNSAnnual Financial Report
5th Apr 202312:36 pmRNSDirector/PDMR Shareholding
5th Apr 202312:30 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
21st Mar 20234:08 pmRNSTransaction in Own Shares
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:11 pmRNSUnaudited NAV and Proposed Final Dividend
21st Feb 20233:10 pmRNSUnaudited Net Asset Value, Proposed Final Dividend
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 202310:17 amRNSDirector/PDMR Shareholding
8th Feb 20239:44 amRNSIssue of Equity
3rd Feb 20233:12 pmRNSProvisional Net Asset Value
23rd Nov 20224:53 pmRNSTransaction in Own Shares
10th Nov 20223:33 pmRNSNet Asset Value(s)
9th Nov 20223:02 pmRNSResult of General Meeting
7th Oct 20224:28 pmRNSPublication of a Prospectus
7th Oct 20229:58 amRNSDirector/PDMR Shareholding
7th Oct 20229:51 amRNSIssue of Equity
4th Oct 20223:30 pmRNSChange of Auditor
3rd Oct 20223:08 pmRNSStatement re Dividend Investment Scheme
6th Sep 20224:48 pmRNSTransaction in Own Shares
2nd Sep 20223:30 pmRNSHalf-year Report
19th Aug 202210:47 amRNSStatement re NAV and Interim Dividend
14th Jul 20229:33 amRNSDirectorate Change
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
24th Jun 20224:13 pmRNSDirectorate Change
9th Jun 20224:18 pmRNSTransaction in Own Shares
6th Jun 20222:15 pmRNSIssue of Equity
20th May 202210:09 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.